Abstract

: Gastroesophageal Reflux Disease (GERD) stands as a prevalent and impactful gastrointes-tinal disorder, affecting a substantial portion of the global population. Characterised by the chronic backflow of stomach acid into the oesophagus, GERD presents itself with symptoms ranging from the discomfort of heartburn to more severe complications, including esophageal inflammation and respiratory issues [1]. The pervasive nature of this condition underscores the critical need for effective and evolving treatment strategies. As individuals worldwide grapple with the challenges posed by GERD, the quest for advancements in treatment options becomes paramount. The prevalence of GERD extends far beyond its physical manifestations, reaching into the realms of daily life, productivity, and overall well-being. Heartburn, regurgitation, and chest pain, hallmarks of GERD, can disrupt sleep patterns, hinder nutritional habits, and compromise the quality of life of an individual [2]. Moreover, the chronic nature of the disease raises concerns about long-term complications, such as Barrett's oesophagus and an increased risk of esophageal cancer. The burden imposed by GERD is not solely physical; it extends to psychological well-being, influencing factors like stress and anxiety. Recognising the multifaceted impact of GERD underscores the urgency of advancing treatment options to address the diverse needs of those affected [3].

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.